PVMCV
Polaris Venture Management Co V Portfolio holdings
AUM
$14.1M
This Quarter Return
-9.88%
1 Year Return
+121.41%
3 Year Return
+278.88%
5 Year Return
+1,121.38%
10 Year Return
–
AUM
$130M
AUM Growth
+$130M
(+5.6%)
Cap. Flow
+$42M
Cap. Flow
% of AUM
32.43%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
1
Increased
–
Reduced
2
Closed
–
Top Buys
| 1 |
TTOO
T2 Biosystems, Inc
TTOO
|
$43M |
Top Sells
| 1 |
GNCA
Genocea Biosciences, Inc.
GNCA
|
$665K |
| 2 |
TRVN
Trevena, Inc.
TRVN
|
$272K |
Sector Composition
| 1 | Healthcare | 53.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TTOO
1
DELISTED
T2 Biosystems, Inc
TTOO
| $43M | 33.15% |
+2,374,571
| New | +$43M |
|
|
TRVN
2
DELISTED
Trevena, Inc.
TRVN
| $24.2M | 18.68% |
3,769,280
-42,402
| -1% | -$272K |
|
|
GNCA
3
DELISTED
Genocea Biosciences, Inc.
GNCA
| $18.6M | 14.35% |
2,055,230
-73,448
| -3% | -$665K |
|
|
BIND
4
DELISTED
BIND THERAPEUTICS INC
BIND
| $17.3M | 13.38% |
2,018,253
| – | – |
|
5
Dare Bioscience
DARE
$27.2M
| $13.9M | 10.71% |
3,287,529
| – | – |
|
6
Fate Therapeutics
FATE
$120M
| $12.6M | 9.73% |
2,473,186
| – | – |
|